Tests:Alpha Fetoprotein, Tumor Marker: Difference between revisions
Tests:Alpha Fetoprotein, Tumor Marker
No edit summary |
No edit summary |
||
| Line 30: | Line 30: | ||
|- | |- | ||
|Preferred | |Preferred | ||
|7 mL Plain <span style="background:#e30022"> | |7 mL Plain<span style="background:#e30022"> Red-Top </span> | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
Revision as of 09:49, 31 January 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | TAFP |
| Synonyms | Tumour Marker (AFP)
AFP (tumour marker) |
| Turnaround Time | 1 hour to 3 days. |
| Stability – Add test | |
| Specimen Requirements | |
| Specimen Type | Serum
Plasma |
| Preferred | 7 mL Plain Red-Top |
| Acceptable | |
| Pediatric Requirements | 0.5 mL Li Hep Microtainer |
| Aliquot Requirements | |
| Sample Type | Serum |
| Minimum Volume | 200 µL |
| Aliquot Transportation | |
| Clinical Information | |
| Reference Intervals | 0 - 16 µg/L (non-pregnant)
See comment |
| Test Method | Ci8200 analyser, Abbott Reagent. |
| Advanced Notice | Not required |
| Patient Preparation | Not required |
| Comments | |
| This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and
certain germ cell cancers, or for patients being monitored after therapy is complete. The test is NOT a screening test for cancer. The test is NOT intended as a screen for neural tube defects. For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |